News
Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback